M. Molzan

发表

Poststroke epilepsy incidence, risk factors and treatment: German claims analysis

M. Holtkamp, J. Wilson, N. Foskett, 2021, Acta neurologica Scandinavica.

Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins

C. Ottmann, M. Molzan, 2012, Cellular & Molecular Biology Letters.

Stabilization of physical RAF/14-3-3 interaction by cotylenin A as treatment strategy for RAS mutant cancers.

M. Skwarczynska, C. Ottmann, M. Schuler, 2013, ACS chemical biology.

Impaired Binding of 14-3-3 to C-RAF in Noonan Syndrome Suggests New Approaches in Diseases with Increased Ras Signaling

C. Ottmann, B. Schumacher, Philipp Thiel, 2010, Molecular and Cellular Biology.

Structural insights of the MLF1/14‐3‐3 interaction

C. Ottmann, M. Weyand, R. Rose, 2012, The FEBS journal.

Activation of NF-κB signalling by fusicoccin-induced dimerization

M. Skwarczynska, C. Ottmann, M. Molzan, 2012, Proceedings of the National Academy of Sciences.

Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database

F. Rosenow, N. Foskett, A. Strzelczyk, 2023, Brain communications.

Synergistic binding of the phosphorylated S233- and S259-binding sites of C-RAF to one 14-3-3ζ dimer.

C. Ottmann, M. Molzan, 2012, Journal of molecular biology.

Supporting Information for Activation of NF-κ B signalling by fusicoccin-induced dimerization

M. Skwarczynska, C. Ottmann, M. Molzan, 2012 .

Activation of NF-κB signalling by fusicoccin-induced dimerization

M. Skwarczynska, M. Molzan, Christian Ottmann, 2012, Proceedings of the National Academy of Sciences.